Results 31 to 40 of about 58,194 (262)

Effectiveness of Vaccination against Pneumococcal Infection in Uzbekistan: a Preliminary Assessmant and Prognosis

Детские инфекции (Москва), 2018
The article is devoted to questions of vaccination against pneumococcal infection in Uzbekistan. Since November 2015, the vaccination against pneumococcal infection with conjugated pneumococcal vaccines of children 1 year of age at the age of 2, 3, 12 ...
T. A. Daminov, L. N. Tuychiev, N. U. Tadjieva, N. Kh. Otamuratova   +3 more
doaj   +1 more source

A brief history of and future prospects for pneumococcal vaccination in Malaysia

Pneumonia, 2023
Pneumococcal pneumonia remains a significant global public health issue. Malaysia has recently added the 10 valent pneumococcal conjugate vaccine to its national immunisation programme.
Alex J. J. Lister, Evelin Dombay, David W. Cleary, Lokman H. Sulaiman, Stuart C. Clarke   +4 more
doaj   +1 more source

Analysis of pneumococcal vaccination status and its influencing factors among young and middle-aged populations: an online survey

Zhongguo gonggong weisheng
ObjectiveTo understand the pneumococcal vaccination status and its influencing factors among young and middle-aged populations, and provide reference for promoting pneumococcal vaccination.
Ziying CHEN, Sijia ZHOU, Xin JIANG, Wen LIU, Yuhang MA, Kai WANG, Zhixiang DAI, Shuhan TANG, Chengxi ZHENG, Jianli HU, Zhihang PENG   +10 more
doaj   +1 more source

Clinical and Immunological Aspects of Pneumococcal Vaccination in Patients with Multiple Myeloma

Эпидемиология и вакцинопрофилактика, 2021
Relevance. Among the groups at high risk of developing invasive pneumococcal infections, patients with multiple myeloma (MM) stand out among the highest rates of morbidity and mortality due to the presence of profound immunosuppression.
I. O. Stoma
doaj   +1 more source

Pneumococcal vaccine and opsonic pneumococcal antibody [PDF]

Journal of Infection and Chemotherapy, 2013
Streptococcus pneumoniae is a major human pathogen responsible for the majority of bacterial pneumonia cases as well as invasive pneumococcal diseases with high mortality and morbidity. Use of conjugate vaccines targeting the pneumococcal capsule has dramatically reduced the incidence of invasive diseases, and there are active efforts to further ...
Joon Young, Song, M Allen, Moseley, Robert L, Burton, Moon H, Nahm   +3 more
openaire   +2 more sources

Pneumococcal Vaccination among Adults with Respiratory Diseases-Indications, Adherence and Roadblocks [PDF]

Journal of Clinical and Diagnostic Research, 2018
Introduction: Globally, invasive pneumococcal disease poses a major challenge to the health system and causes significant economic burden. Pneumococcal vaccination is a recommended and well adhered practice among paediatric age groups as opposed to adult
Divya Ramachandran, Rajesh Venkitakrishnan, Jolsana Augustine, Melcy Cletus   +3 more
doaj   +1 more source

Clinical Outcomes of Patients Within the Rheumatoid Arthritis Care Pathway Cohort at a Tertiary Care Integrated Delivery Network: A Comparison to Usual Care

Arthritis Care &Research, EarlyView.
Objective We aimed to compare clinical outcomes between patients in the Allegheny Health Network rheumatoid arthritis (RA) care pathway and patients receiving usual care. Methods The care pathway initiative implements guideline‐based best practice alongside multidisciplinary team‐based care.
Tarun Sharma, Tyson S. Barrett, Teigan Dwyer, Nancy Campbell, Jessica Heintzinger, Ellen Kraemer, Adam Dore, Susan Manzi   +7 more
wiley   +1 more source

PD‐1 Inhibits CD4+ TRM‐Mediated cDC1 Mobilization via Suppressing JAML in Human NSCLC

Advanced Science, EarlyView.
CD4+ tissue‐resident memory T cells (TRMs) in non‐small cell lung cancer recruit conventional type 1 dendritic cells via XCL1‐XCR1 signaling, orchestrating antitumor immunity. The costimulatory molecule JAML is essential for this process. PD‐1 blockade restores JAML expression and cDC1 mobilization, while JAML agonists synergize with anti‐PD‐1 therapy,
Zheyu Shao, Qinyuan Liu, Zhongwei Xin, Zhiyao Zhou, Mingjie Lin, Di Chen, Zhixing Hao, Yongyuan Chen, Wenxuan Wu, Shuyang Zhang, Xiaoke Chen, Xia Xu, Jinfan Li, Wei Lin, Yuhao Lu, Dang Wu, Pin Wu   +16 more
wiley   +1 more source

An economic analysis of a pneumococcal vaccine programme in people aged over 64 years in a developed country setting. [PDF]

, 2005
BACKGROUND: Polysaccharide pneumococcal vaccination for older adults is being introduced in developed country settings. Evidence of protection by this vaccine against pneumococcal pneumonia, or confirmation that illness and death from bacteraemia are ...
Cutts, Felicity T, Hall, Andrew J, Mangtani, Punam, Roberts, Jennifer A   +3 more
core   +1 more source

Engineering Tertiary Lymphoid Structures: Nanomedicine, Bioengineering, and Biomaterials for Precision Immunotherapy

Advanced NanoBiomed Research, EarlyView.
This review explains how biomaterials and nanoparticles can be used to induce or modulate tertiary lymphoid structures (TLSs), which are ectopic immune hubs that form in nonlymphoid tissues during chronic disease and cancer. By comparing different methods, the article highlights design principles for modeling TLSs or recapitulating specific TLS ...
Shaza Karaman, Mei ElGindi, Jeremy Teo
wiley   +1 more source